CD4+ T cells may enhance anticancer effect by providing help to CD8+ T cells through facilitation of dendritic cell (DC) - T cell interactions [16] or, directly recognizing endogenously processed antigens displayed on the surface of tumors followed by secretion of type 1 cytokines [26, 27] or direct cancer cell killing [28]. This evidence concerns the gene CD8A and cancer.